Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

Pieter Dewint; Bettina E Hansen; Elke Verhey; Bas Oldenburg; Daniel W Hommes; Marieke Pierik; Cyriel I J Ponsioen; Hendrik M van Dullemen; Maurice Russel; Ad A van Bodegraven; C Janneke van der Woude

doi:10.1136/gutjnl-2013-304488

Article info

Inflammatory bowel disease

Original article

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

Authors

Pieter Dewint Department of Gastroenterology and Hepatology, Erasmus MC Rotterdam, Rotterdam, The Netherlands PubMed articles Google scholar articles
Bettina E Hansen Department of Gastroenterology and Hepatology, Erasmus MC Rotterdam, Rotterdam, The Netherlands PubMed articles Google scholar articles
Elke Verhey Department of Gastroenterology and Hepatology, Erasmus MC Rotterdam, Rotterdam, The Netherlands PubMed articles Google scholar articles
Bas Oldenburg Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands PubMed articles Google scholar articles
Daniel W Hommes Department of Gastroenterology and Hepatology, University Medical Center Leiden, Leiden, The Netherlands PubMed articles Google scholar articles
Marieke Pierik Department of Gastroenterology and Hepatology, University Medical Center Maastricht, Maastricht, The Netherlands PubMed articles Google scholar articles
Cyriel I J Ponsioen Department of Gastroenterology and Hepatology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands PubMed articles Google scholar articles
Hendrik M van Dullemen Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, Groningen, The Netherlands PubMed articles Google scholar articles
Maurice Russel Department of Gastroenterology and Hepatology, Medisch Spectrum Twente, Enschede, The Netherlands PubMed articles Google scholar articles
Ad A van Bodegraven Department of Gastroenterology and Hepatology, VU University Medical Center Amsterdam, Amsterdam, The Netherlands PubMed articles Google scholar articles
C Janneke van der Woude Department of Gastroenterology and Hepatology, Erasmus MC Rotterdam, Rotterdam, The Netherlands PubMed articles Google scholar articles

Correspondence to Dr C Janneke van der Woude, Department of Gastroenterology and Hepatology, Erasmus MC Rotterdam, ‘s Gravendijkwal 230, Rotterdam 3015 CE, The Netherlands; c.vanderwoude{at}erasmusmc.nl

View Full Text

Citation

Dewint P, Hansen BE, Verhey E, et al

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

Gut 2014;63:292-299.

Publication history

Received January 9, 2013
Revised February 22, 2013
Accepted February 22, 2013
First published March 23, 2013.

Online issue publication

October 26, 2017

Article Versions

Previous version (18 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password